Sheridan was organized in Delaware as a limited partnership in 2018 and is located in Chicago,
Illinois. Sheridan is indirectly owned by Jonathan Lewis and Sean Dempsey (the “Principals”)
through their interest in Sheridan’s general partner.
Sheridan currently provides investment advisory services to private pooled investment vehicles. On a
discretionary basis, Sheridan manages Sheridan Capital Partners Fund II, LP and Sheridan Capital
Partners Fund II-A, LP (together, “Fund II”) and Sheridan Capital Partners Fund III, LP and Sheridan
Capital Partners Fund III-A, LP, (together, “Fund III”).
Fund II and Fund III are collectively referred to herein as the “Funds” or “Clients”. Information about
each Fund can be found in its respective offering documents, such as private placement
memorandums, limited partnership agreements, and/or advisory agreements, as applicable (the
“Offering Documents”). Investment
advice is provided directly to the Funds, subject to the discretion
and control of the applicable Fund’s general partner (“General Partner” or “General Partners”), and
not individually to the Funds’ limited partners (each, a “Limited Partner” and collectively, the
“Limited Partners”).
As of December 31, 2023, Sheridan Capital Partners no longer provides advisory services to
Sheridan Legacy Fund I, L.P. (“Legacy Fund”).
Sheridan is a lower middle-market (“LMM”) private equity firm focused exclusively on the
healthcare industry. Sheridan seeks to make control-oriented investments in LMM healthcare
businesses in the United States and Canada. The investments made by the Funds are referred to
herein as “Portfolio Companies”.
As of December 31, 2023, Sheridan’s regulatory assets under management were approximately
$1,045,061,045, of which $8,671,375 is managed on a non-discretionary basis.